SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Emerging Diagnostic Technologies in the Changing U.S. Market
[December 19, 2012]

Emerging Diagnostic Technologies in the Changing U.S. Market

NEW YORK, Dec. 19, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Emerging Diagnostic Technologies in the Changing U.S. Market http://www.reportlinker.com/p01057714/Emerging-Diagnostic-Technologies-in-the-Changing-US-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging INTRODUCTION STUDY BACKGROUND The U.S. market for medical diagnostic products and services has been growing strongly in recent years, driven by favorable reimbursement policies for clinical lab testing, increasing awareness of the need for early disease detection and the health needs of an increasingly elderly population. Another factor driving the diagnostic market has been the development of new diagnostic technologies that open the way to new applications, while increasing the accuracy, reliability and relative comfort of existing applications.GOALS AND OBJECTIVES The overall goal of this study is to provide the reader with an up-to-date understanding of the emerging diagnostic technologies that will influence the future size and structure of the market for medical diagnostics. Specific objectives include the following: Identifying the new diagnostic technologies with the greatest potential to influence the diagnostic market in the near to mid-term (2012 to 2017).Analyzing the key drivers and constraints that will shape the market for these technologies over the next five years.Estimating the current and future demand for each of these technologies through 2017.

INTENDED AUDIENCE The report is intended especially for vendors of medical diagnostic devices and services, as well as government agencies, healthcare policy analysts and others seeking to understand the medical applications of new diagnostic technologies. Although the report focuses on specific technologies, it is largely nontechnical in nature. That is, it is concerned less with theory and jargon than with what works and how much of it the market is likely to purchase.

As such, the report's main audience is executive management, marketing and financial analysts. It is not written specifically for scientists and technologists, although its findings concerned the market for their work, including the availability of government and corporate research funding for different technologies and applications.


SCOPE AND FORMAT This report addresses the U.S. market for emerging diagnostic technologies. Of course, terms such as emerging or new are relative in a rapidly evolving market such as medical diagnostics. Thus, this report pragmatically defines emerging diagnostic technologies as those that are only in limited commercial use and/or in advanced development as of 2012. Also included are certain technologies, such as telemedicine, that have been in use for more than a few years, but which have the potential today to cause a fundamental or paradigm shift in the way diagnoses are performed. The technologies covered fall into the following categories: Ultrasound.Magnetic resonance imaging.Nuclear medicine.Computed tomography.Photonics, optics and spectroscopy.Hybrid imaging technologies.Telediagnosis.Laboratory information systems.Diagnostic decision support systems.Imaging agents.Terahertz technology.Wireless devices.Other technologies.

The format of the study includes the following elements: Summary.Definitions.Developments in enabling technologies.Key end-user segments.Market environment (legal and regulatory, standards, trends in the healthcare industry, demographic and economic trends, other market drivers and barriers to deployment).Emerging diagnostic technologies and products.Detailed market estimates and projections, by type of diagnostic technology and product, 2011 to 2017.Supplier profiles.Patent analysis.

METHODOLOGY Both primary and secondary research methodologies were used in preparing this research report. The findings and conclusions of this report are based on information gathered from developers, vendors, integrators and users of medical diagnostic devices. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature and online databases to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2011. With 2011 as a baseline, market projections were developed for 2012 to 2017. The projections are based on a combination of a consensus among the primary contacts combined with BCC's understanding of the key market drivers and their impact from historical and analytical perspectives.

The specific assumptions and approach that BCC used to develop the projections (both near/mid-term and long-term) for each application are documented in detail under the various segments addressed. This way, readers can see how the market estimates were developed and, if they so desire, test the impact on the final numbers of changing assumptions regarding such matters as date of regulatory approval.

One of the approaches used by BCC deserves special mention here. Particularly in the case of diagnostic technologies that have not yet reached the market, BCC used the sales performance of existing technologies that share some of the same functions or other characteristics as emerging diagnostic technology in question as a benchmark for assessing the latter's sales potential.

All dollar projections presented in this report are in 2011 constant U.S. dollars.

AUTHOR'S CREDENTIALS The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm 43rd Parallel, LLC, is the author of several other BCC Research studies of the healthcare and related industries, including HLC016D Microelectronic Medical Implants: Products, Technologies and Opportunities; HLC036D Medical Robotics and Computer-Assisted Surgery: The Global Market; HLC042A Radiation-based Therapy and Therapeutic Imaging; HLC051F The Market for Minimally Invasive Medical Devices; HLC038C Patient Monitoring; HLC054B Home Medical Equipment: Technologies and Global Markets; HLC014E Global Markets for Telemedicine Technologies; HLC048C Healthcare Information Technology; HLC066B Medical Automation Technologies, Products and Markets; HLC070A Preventive Healthcare Technologies, Products and Markets; and HLC072B Global Markets and Technologies for Medical Lasers.

TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY BACKGROUND 1 GOALS AND OBJECTIVES 1 INTENDED AUDIENCE 1 SCOPE AND FORMAT 1 METHODOLOGY 2 AUTHOR'S CREDENTIALS 3 RELATED BCC RESEARCH 3 BCC ON-LINE SERVICES 3 DISCLAIMER 4 CHAPTER 2 SUMMARY 6 SUMMARY TABLE U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 6 SUMMARY FIGURE U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 6 CHAPTER 3 OVERVIEW 9 DEFINITIONS 9 DIAGNOSTIC TECHNOLOGIES 9 EMERGING TECHNOLOGIES 9 ENABLING TECHNOLOGIES 9 AUTOMATION/ROBOTICS 10 Automated Health Assessment and Monitoring 10 Automated Imaging and Image Analysis 10 Automated Laboratory Testing and Analysis 10 WIRELESS COMMUNICATIONS AND NETWORKING 11 Improved Sensors 11 Data Access and Sharing 11 Remote Diagnostics 12 ADVANCED SENSORS 12 Parameters Measured 12 Micro- and Nanosensors 13 Sensing Fabrics and Wearable Monitors 13 ARTIFICIAL INTELLIGENCE 14 END-USER SEGMENTS 15 HOSPITALS 15 FIGURE 1 TREND IN THE NUMBER OF U.S. HOSPITALS, 1995-2010 (UNITS) 15 PHYSICIAN PRACTICES 16 FIGURE 2 TREND IN THE NUMBER OF ACTIVE U.S. PHYSICIANS, 2002-2009 (THOUSANDS) 16 TABLE 1 DISTRIBUTION OF U.S. PHYSICIANS BY PRACTICE SETTING/SIZE, 1996-2008 (%) 17 HOME CARE 17 FIGURE 3 TRENDS IN U.S. EXPENDITURES ON HOME HEALTHCARE, 2000-2010 ($ BILLIONS) 18 MILITARY 18 FIGURE 4 U.S. MILITARY HEALTH EXPENDITURES, FY 2000-FY 2011 ($ BILLIONS) 18 MEDICAL RESEARCH/CLINICAL LABORATORIES 19 EMERGING DIAGNOSTIC TECHNOLOGIES AND PRODUCTS 20 TABLE 2 EMERGING DIAGNOSTIC TECHNOLOGIES 20 ULTRASOUND 20 MAGNETIC RESONANCE IMAGING 21 NUCLEAR MEDICINE 21 COMPUTED TOMOGRAPHY 21 PHOTONICS, OPTICS AND SPECTROSCOPY 21 HYBRID IMAGING TECHNOLOGIES 22 TELEDIAGNOSIS 22 LABORATORY INFORMATION SYSTEMS 22 DIAGNOSTIC DECISION SUPPORT SYSTEMS 22 IMAGING AGENTS 22 TERAHERTZ TECHNOLOGY 23 WIRELESS DEVICES 23 OTHER TECHNOLOGIES 23 MARKET SUMMARY 23 TECHNOLOGY SEGMENTS 23 TABLE 3 U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 24 LEADING PRODUCTS 24 TABLE 4 NEW DIAGNOSTIC PRODUCTS EXPECTED TO SHOW LARGEST GAINS IN DOLLAR SALES, 2011-2017 ($ MILLIONS) 25 CHAPTER 4 MARKET ENVIRONMENT 27 LEGAL/REGULATORY ENVIRONMENT 27 U.S. FOOD AND DRUG ADMINISTRATION 27 MEDICARE/MEDICAID 29 PATIENT PROTECTION AND AFFORDABLE CARE ACT 29 ECONOMIC TRENDS 30 DEMOGRAPHIC TRENDS 31 OVERALL POPULATION GROWTH 31 TABLE 5 TRENDS IN TOTAL U.S. POPULATION, THROUGH 2017 (MILLION PEOPLE) 31 INCREASE IN THE NUMBER OF ELDERLY PEOPLE 31 TABLE 6 U.S. POPULATION AGED 65 YEARS AND OLDER, THROUGH 2017 (MILLION PEOPLE) 31 EPIDEMIOLOGICAL TRENDS 31 CARDIOVASCULAR DISEASE 32 TABLE 7 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2009 32 CANCER 32 TRENDS IN THE HEALTHCARE INDUSTRY 33 RISING COSTS 33 FIGURE 5 TRENDS IN U.S. PER CAPITA HEALTHCARE COSTS, 1990-2010 ($ PER PERSON) 33 DECLINING REIMBURSEMENT RATES 34 SHORTAGES OF HEALTHCARE PERSONNEL/INCREASING WORKLOADS 34 Physicians 34 Nurses 34 CHAPTER 5 INTELLECTUAL PROPERTY 36 FIGURE 6 U.S. PATENTS RELATING TO EMERGING DIAGNOSTIC TECHNOLOGIES (NUMBER OF PATENTS /% OF TOTAL PATENTS/) 36 FIGURE 7 U.S. PATENTS RELATING TO EMERGING DIAGNOSTIC TECHNOLOGIES (% OF TOTAL PATENTS/NUMBER OF PATENTS) 38 CHAPTER 6 EMERGING ULTRASOUND TECHNOLOGIES 40 SUMMARY 40 TECHNOLOGIES 40 AUTOMATED BREAST ULTRASOUND 40 ROBOTIC ULTRASOUND 41 REMOTE ULTRASOUND 41 CURRENT STATUS 42 MARKET ASSESSMENT 42 TABLE 8 U.S. MARKET FOR EMERGING DIAGNOSTIC ULTRASOUND TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 43 FIGURE 8 TRENDS IN U.S. DIAGNOSTIC ULTRASOUND MARKET, 2011-2017 ($ MILLIONS) 43 AUTOMATED BREAST ULTRASOUND 43 TABLE 9 U.S. MARKET FOR AUTOMATED BREAST ULTRASOUND, THROUGH 2017 ($ MILLIONS) 44 ROBOTIC AND REMOTE ULTRASOUND 44 TABLE 10 U.S. MARKET FOR REMOTE AND ROBOTIC DIAGNOSTIC ULTRASOUND, THROUGH 2017 ($ MILLIONS) 44 CHAPTER 7 EMERGING MRI TECHNOLOGIES 46 SUMMARY 46 TECHNOLOGIES 46 COMPUTER-ASSISTED MRI DETECTION 46 ULTRA-LOW FIELD MRI 47 MAGNETOENCEPHALOGRAPHY 47 CURRENT STATUS 48 MARKET ASSESSMENT 49 TABLE 11 U.S. MARKET FOR EMERGING DIAGNOSTIC MRI TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 49 FIGURE 9 TRENDS IN U.S. DIAGNOSTIC MRI MARKET, 2011-2017 ($ MILLIONS) 49 COMPUTER-ASSISTED DIAGNOSTIC MRI 50 TABLE 12 U.S. MARKET FOR COMPUTER-ASSISTED DIAGNOSTIC MRI TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 50 ULTRA-LOW FIELD MRI AND MRI/MEG 50 TABLE 13 U.S. MARKET FOR EMERGING DIAGNOSTIC MRI TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 51 CHAPTER 8 EMERGING NUCLEAR MEDICINE DIAGNOSTIC TECHNOLOGIES 53 SUMMARY 53 TECHNOLOGIES 53 PETRRA 53 HANDHELD GAMMA CAMERAS 53 CURRENT STATUS 54 MARKET ASSESSMENT 54 TABLE 14 U.S. MARKET FOR EMERGING NUCLEAR MEDICINE DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 55 FIGURE 10 TRENDS IN U.S. MARKET FOR EMERGING NUCLEAR MEDICINE DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 55 PETTRA 55 TABLE 15 U.S. MARKET FOR PETTRA DEVICES, THROUGH 2017 ($ MILLIONS) 55 HANDHELD GAMMA CAMERAS 56 TABLE 16 U.S. MARKET FOR HANDHELD GAMMA CAMERAS, THROUGH 2017 ($ MILLIONS) 56 CHAPTER 9 EMERGING TOMOGRAPHIC DIAGNOSTIC TECHNOLOGIES 58 SUMMARY 58 TECHNOLOGIES 58 VIRTUAL COLONOSCOPY 58 DIGITAL TOMOSYNTHESIS 59 CURRENT STATUS 59 MARKET ASSESSMENT 60 TABLE 17 U.S. MARKET FOR EMERGING TOMOGRAPHIC DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 60 FIGURE 11 TRENDS IN U.S. MARKET FOR EMERGING TOMOGRAPHIC DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 60 VIRTUAL COLONOSCOPY 61 TABLE 18 U.S. MARKET FOR VIRTUAL COLONOSCOPY SOFTWARE AND CAD SYSTEMS, THROUGH 2017 ($ MILLIONS) 61 BREAST TOMOSYNTHESIS 62 TABLE 19 U.S. MARKET FOR BREAST TOMOSYNTHESIS SYSTEMS, THROUGH 2017 ($ MILLIONS) 62 CHAPTER 10 DEVELOPMENTS IN PHOTONICS, OPTICS AND SPECTROSCOPY 64 SUMMARY 64 TECHNOLOGIES 64 QUANTUM DOTS 64 NEAR-INFRARED SPECTROSCOPY 65 SPATIALLY RESOLVED SPECTROSCOPY 65 OPTICAL COHERENCE TOMOGRAPHY 65 CURRENT STATUS 66 MARKET ASSESSMENT 66 TABLE 20 U.S. MARKET FOR EMERGING PHOTONIC, OPTICAL AND SPECTROSCOPIC DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 67 FIGURE 12 TRENDS IN U.S. MARKET FOR EMERGING PHOTONIC, OPTICAL AND SPECTROSCOPIC DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 67 QUANTUM DOTS 67 TABLE 21 U.S. MARKET FOR QUANTUM DOTS USED IN DIAGNOSTIC APPLICATIONS, THROUGH 2017 ($ MILLIONS) 68 NEAR INFRARED 68 TABLE 22 U.S. MARKET FOR NIR DIAGNOSTIC DEVICES, THROUGH 2017 ($ MILLIONS) 68 OPTICAL COHERENCE TOMOGRAPHY 68 TABLE 23 U.S. MARKET FOR OCT DIAGNOSTIC DEVICES, THROUGH 2017 ($ MILLIONS) 69 CHAPTER 11 DEVELOPMENTS IN HYBRID TECHNOLOGIES 71 SUMMARY 71 TECHNOLOGIES 71 PET/MRI 71 PHOTOACOUSTIC TOMOGRAPHY 72 CURRENT STATUS 72 MARKET ASSESSMENT 72 TABLE 24 U.S. MARKET FOR EMERGING HYBRID DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 73 FIGURE 13 TRENDS IN U.S. MARKET FOR EMERGING HYBRID DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 73 PET/MRI 73 TABLE 25 U.S. MARKET FOR PET/MRI SCANNERS, THROUGH 2017 ($ MILLIONS) 74 PHOTOACOUSTIC TOMOGRAPHY 74 TABLE 26 U.S. MARKET FOR PAT SCANNERS, THROUGH 2017 ($ MILLIONS) 74 CHAPTER 12 EMERGING TELEDIAGNOSTIC TECHNOLOGIES 76 SUMMARY 76 TECHNOLOGIES 76 VIDEOCONFERENCING 76 REAL-TIME, STORE-AND-FORWARD AND HYBRID TELECONFERENCING 77 IP-BASED VIDEOCONFERENCING 77 PERIPHERAL DEVICES 77 CURRENT STATUS 78 MARKET ASSESSMENT 78 TABLE 27 U.S. MARKET FOR TELEDIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 78 FIGURE 14 TRENDS IN U.S. MARKET FOR TELEDIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 78 VIDEOCONFERENCING 79 TABLE 28 U.S. MARKET FOR TELEMEDICINE VIDEOCONFERENCING EQUIPMENT, THROUGH 2017 ($ MILLIONS) 79 PERIPHERALS 79 TABLE 29 U.S. MARKET FOR TELEMEDICINE VIDEOCONFERENCING PERIPHERAL DEVICES, THROUGH 2017 ($ MILLIONS) 80 CHAPTER 13 DEVELOPMENTS IN LABORATORY INFORMATION SYSTEMS 82 SUMMARY 82 TECHNOLOGIES 82 INTEROPERABILITY ISSUES 82 DATA STANDARDS 83 CURRENT STATUS 83 MARKET ASSESSMENT 84 TABLE 30 U.S. MARKET FOR DIAGNOSTIC LIS, THROUGH 2017 ($ MILLIONS) 84 FIGURE 15 TRENDS IN U.S. MARKET FOR DIAGNOSTIC LIS, 2011-2017 ($ MILLIONS) 84 CHAPTER 14 DEVELOPMENTS IN DIAGNOSTIC DECISION SUPPORT SYSTEMS 87 SUMMARY 87 TECHNOLOGIES 87 KNOWLEDGE-BASED SYSTEMS 87 Expert Systems 87 Probabilistic Systems 89 Bayesian Network 89 Heuristic Systems 89 NON-KNOWLEDGE-BASED SYSTEMS 90 Artificial Neural Networks 90 Genetic Algorithms 91 CURRENT STATUS 91 MARKET ASSESSMENT 92 TABLE 31 U.S. MARKET FOR DIAGNOSTIC DECISION SUPPORT SYSTEMS, THROUGH 2017 ($ MILLIONS) 92 FIGURE 16 TRENDS IN U.S. MARKET FOR DIAGNOSTIC DECISION SUPPORT SYSTEMS, 2011-2017 ($ MILLIONS) 93 CHAPTER 15 DEVELOPMENTS IN IMAGING AGENTS 95 SUMMARY 95 TECHNOLOGIES 95 SUPERPARAMAGNETIC MRI CONTRAST AGENTS 95 APTAMERS 96 NANOPARTICLE-BASED OPTICAL IMAGING AGENTS 96 NANOSHELLS 97 CURRENT STATUS 97 MARKET ASSESSMENT 97 TABLE 32 U.S. MARKET FOR EMERGING DIAGNOSTIC IMAGING AGENTS, THROUGH 2017 ($ MILLIONS) 97 FIGURE 17 TRENDS IN U.S. MARKET FOR EMERGING DIAGNOSTIC IMAGING AGENTS, 2011â 2017 ($ MILLIONS) 98 SUPERPARAMAGNETIC MRI CONTRAST AGENTS 99 TABLE 33 U.S. MARKET FOR SUPERPARAMAGNETIC MRI CONTRAST AGENTS, THROUGH 2017 ($ MILLIONS) 99 HYPERPOLARIZED IMAGING AGENTS 99 TABLE 34 U.S. MARKET FOR HYPERPOLARIZED MRI CONTRAST AGENTS, THROUGH 2017 ($ MILLIONS) 100 APTAMERS 100 TABLE 35 U.S. MARKET FOR APTAMER-BASED IMAGING AGENTS, THROUGH 2017 ($ MILLIONS) 100 OTHER NANOPARTICLE-BASED OPTICAL IMAGING AGENTS 100 TABLE 36 U.S. MARKET FOR NANOPARTICLE-BASED OPTICAL IMAGING AGENTS, THROUGH 2017 ($ MILLIONS) 101 NANOSHELLS 101 TABLE 37 U.S. MARKET FOR NANOSHELL-BASED OPTICAL IMAGING AGENTS, THROUGH 2017 ($ MILLIONS) 101 CHAPTER 16 EMERGING DIAGNOSTIC APPLICATIONS OF THZ RADIATION 103 SUMMARY 103 TECHNOLOGIES 103 DIGITAL DERMOSCOPES 103 ENDOSCOPES 104 THZ TOMOGRAPHIC INSTRUMENTS 105 THZ BIOCHIPS 105 CURRENT STATUS 105 MARKET ASSESSMENT 106 TABLE 38 U.S. MARKET FOR DIAGNOSTIC APPLICATIONS OF THZ RADIATION, THROUGH 2017 ($ MILLIONS) 106 FIGURE 18 TRENDS IN U.S. MARKET FOR EMERGING TERAHERTZ DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 107 DIGITAL DERMOSCOPES 107 TABLE 39 U.S. MARKET FOR TERAHERTZ SKIN CANCER IMAGING EQUIPMENT, THROUGH 2017 ($ MILLIONS) 107 ENDOSCOPES 107 TABLE 40 U.S. MARKET FOR TERAHERTZ ENDOSCOPES, THROUGH 2017 ($ MILLIONS) 108 TOMOGRAPHIC INSTRUMENTS 108 TABLE 41 U.S. MARKET FOR TERAHERTZ BURN DIAGNOSTIC INSTRUMENTS THROUGH 2017 ($ MILLIONS) 108 THZ BIOCHIPS 109 TABLE 42 U.S. MARKET FOR TERAHERTZ BIOCHIPS USED IN MEDICAL DIAGNOSTICS APPLICATIONS, THROUGH 2017 ($ MILLIONS) 109 CHAPTER 17 DEVELOPMENTS IN WIRELESS DIAGNOSTIC DEVICES 111 SUMMARY 111 TECHNOLOGIES 111 NFC-ENABLED MOBILE DIAGNOSTIC DEVICES 111 CAPSULE ENDOSCOPY 112 CURRENT STATUS 113 MARKET ASSESSMENT 113 TABLE 43 U.S. MARKET FOR EMERGING WIRELESS DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 113 FIGURE 19 TRENDS IN U.S. MARKET FOR EMERGING WIRELESS DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 114 NFC-ENABLED MOBILE DEVICE DIAGNOSTICS 114 TABLE 44 U.S. MARKET FOR NFC-ENABLED MOBILE DEVICE DIAGNOSTICS, THROUGH 2017 ($ MILLIONS) 115 CAPSULE ENDOSCOPY SYSTEMS 115 TABLE 45 U.S. MARKET FOR CAPSULE ENDOSCOPY SYSTEMS, THROUGH 2017 ($ MILLIONS) 115 CHAPTER 18 OTHER EMERGING DIAGNOSTIC TECHNOLOGIES 117 SUMMARY 117 TECHNOLOGIES 117 "ELECTRONIC NOSES" 117 DENDRIMER-BASE D DIAGNOSTIC REAGENTS 118 CURRENT STATUS 118 MARKET ASSESSMENT 118 TABLE 46 U.S. MARKET FOR OTHER EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 118 FIGURE 20 TRENDS IN U.S. MARKET OTHER EMERGING DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 118 ELECTRONIC NOSES 119 TABLE 47 U.S. MARKET FOR DIAGNOSTIC ELECTRONIC NOSES, THROUGH 2017 ($ MILLIONS) 119 DENDRIMER-BASED REAGENTS 119 TABLE 48 U.S. MARKET FOR DENDRIMER-BASED DIAGNOSTIC REAGENTS, THROUGH 2017 ($ MILLIONS) 120 CHAPTER 19 APPENDIX A: COMPANY PROFILES 122 ULTRASOUND TECHNOLOGIES 122 HELIX MEDICAL SYSTEMS, LTD. 122 TECHNISCAN MEDICAL SYSTEMS 122 U-SYSTEMS, INC. 122 MRI TECHNOLOGIES 123 ICAD INC. 123 INVIVO CORP. 123 MERGE HEALTHCARE 123 TOMOGRAPHIC AND NUCLEAR MEDICINE TECHNOLOGIES 124 CRYSTAL PHOTONICS GMBH 124 HOLOGIC 124 HYBRIDYNE IMAGING TECHNOLOGIES 124 INTRAMEDICAL IMAGING LLC 125 PETRRA LTD. 125 PHOTONIC, OPTICAL AND SPECTROSCOPIC TECHNOLOGIES 125 CARL ZEISS MEDITEC AG 125 EVIDENT TECHNOLOGIES 125 HEIDELBERG ENGINEERING 126 INFRAREDX, INC. 126 INFRASCAN INC. 127 LIFE TECHNOLOGIES CORP. 127 TOMOPHASE CORP. 128 HYBRID TECHNOLOGIES 128 ENDRA, INC. 128 VISUALSONICS, INC. 128 TELEDIAGNOSTIC TECHNOLOGIES 129 GLOBALMEDIA GROUP LLC 129 INTERNATIONAL BUSINESS MACHINES CORP. 129 INTOUCH TECHNOLOGIES 129 POLYCOM 130 ROCHE DIAGNOSTICS 130 SIEMENS HEALTHCARE 130 LABORATORY INFORMATION SYSTEMS 131 COMPUGROUP MEDICAL - LAB DIVISION 131 MCKESSON CORP. 131 CLINICAL DECISION SUPPORT SYSTEMS 131 ISABEL HEALTHCARE INC. 131 LIFECOM, INC. 132 LOGICAL IMAGES, INC. 132 MASSACHUSETTS GENERAL HOSPITAL 132 MEDRX 133 ONTOLOGY WORKS, INC. 133 PROBLEM-KNOWLEDGE COUPLERS 133 IMAGING AGENTS AND RADIATION PROBES 134 BAYER SCHERING PHARMA AG 134 NANOSPECTRA BIOSCIENCES, INC. 134 PERKINELMER, INC. 135 XEMED LLC 135 TERAHERTZ IMAGING APPLICATIONS 136 CANON INC. 136 M SQUARED LASERS LTD. 136 SPIRE CORP. 136 TERASENSE DEVELOPMENT LABS LLC 137 VERISANTE TECHNOLOGY INC. 137 WIRELESS AND NETWORKED DEVICES 137 GENTAG, INC. 137 GIVEN IMAGING, LTD. 138 OTHER TECHNOLOGIES 138 SIEMENS HEALTHCARE 138 LIST OF TABLES SUMMARY TABLE U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH2017 ($ MILLIONS) 6TABLE 1 DISTRIBUTION OF U.S. PHYSICIANS BY PRACTICE SETTING/SIZE, 1996-2008 (%) 17TABLE 2 EMERGING DIAGNOSTIC TECHNOLOGIES 20TABLE 3 U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($MILLIONS) 24TABLE 4 NEW DIAGNOSTIC PRODUCTS EXPECTED TO SHOW LARGEST GAINS IN DOLLARSALES, 2011-2017 ($ MILLIONS) 25TABLE 5 TRENDS IN TOTAL U.S. POPULATION, THROUGH 2017 (MILLION PEOPLE) 31TABLE 6 U.S. POPULATION AGED 65 YEARS AND OLDER, THROUGH 2017 (MILLION PEOPLE) 31TABLE 7 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS AND DEATHS DUE TO HEARTDISEASE IN THE U.S., 2009 32TABLE 8 U.S. MARKET FOR EMERGING DIAGNOSTIC ULTRASOUND TECHNOLOGIES,THROUGH 2017 ($ MILLIONS) 43TABLE 9 U.S. MARKET FOR AUTOMATED BREAST ULTRASOUND, THROUGH 2017 ($MILLIONS) 44TABLE 10 U.S. MARKET FOR REMOTE AND ROBOTIC DIAGNOSTIC ULTRASOUND, THROUGH2017 ($ MILLIONS) 44TABLE 11 U.S. MARKET FOR EMERGING DIAGNOSTIC MRI TECHNOLOGIES, THROUGH 2017($ MILLIONS) 49TABLE 12 U.S. MARKET FOR COMPUTER-ASSISTED DIAGNOSTIC MRI TECHNOLOGIES,THROUGH 2017 ($ MILLIONS) 50TABLE 13 U.S. MARKET FOR EMERGING DIAGNOSTIC MRI TECHNOLOGIES, THROUGH 2017($ MILLIONS) 51TABLE 14 U.S. MARKET FOR EMERGING NUCLEAR MEDICINE DIAGNOSTIC TECHNOLOGIES,THROUGH 2017 ($ MILLIONS) 55TABLE 15 U.S. MARKET FOR PETTRA DEVICES, THROUGH 2017 ($ MILLIONS) 55TABLE 16 U.S. MARKET FOR HANDHELD GAMMA CAMERAS, THROUGH 2017 ($ MILLIONS) 56TABLE 17 U.S. MARKET FOR EMERGING TOMOGRAPHIC DIAGNOSTIC TECHNOLOGIES,THROUGH 2017 ($ MILLIONS) 60TABLE 18 U.S. MARKET FOR VIRTUAL COLONOSCOPY SOFTWARE AND CAD SYSTEMS,THROUGH 2017 ($ MILLIONS) 61TABLE 19 U.S. MARKET FOR BREAST TOMOSYNTHESIS SYSTEMS, THROUGH 2017 ($MILLIONS) 62TABLE 20 U.S. MARKET FOR EMERGING PHOTONIC, OPTICAL AND SPECTROSCOPICDIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 67TABLE 21 U.S. MARKET FOR QUANTUM DOTS USED IN DIAGNOSTIC APPLICATIONS,THROUGH 2017 ($ MILLIONS) 68TABLE 22 U.S. MARKET FOR NIR DIAGNOSTIC DEVICES, THROUGH 2017 ($ MILLIONS) 68TABLE 23 U.S. MARKET FOR OCT DIAGNOSTIC DEVICES, THROUGH 2017 ($ MILLIONS) 69TABLE 24 U.S. MARKET FOR EMERGING HYBRID DIAGNOSTIC TECHNOLOGIES, THROUGH2017 ($ MILLIONS) 73TABLE 25 U.S. MARKET FOR PET/MRI SCANNERS, THROUGH 2017 ($ MILLIONS) 74TABLE 26 U.S. MARKET FOR PAT SCANNERS, THROUGH 2017 ($ MILLIONS) 74TABLE 27 U.S. MARKET FOR TELEDIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($MILLIONS) 78TABLE 28 U.S. MARKET FOR TELEMEDICINE VIDEOCONFERENCING EQUIPMENT, THROUGH2017 ($ MILLIONS) 79TABLE 29 U.S. MARKET FOR TELEMEDICINE VIDEOCONFERENCING PERIPHERAL DEVICES,THROUGH 2017 ($ MILLIONS) 80TABLE 30 U.S. MARKET FOR DIAGNOSTIC LIS, THROUGH 2017 ($ MILLIONS) 84TABLE 31 U.S. MARKET FOR DIAGNOSTIC DECISION SUPPORT SYSTEMS, THROUGH 2017 ($MILLIONS) 92TABLE 32 U.S. MARKET FOR EMERGING DIAGNOSTIC IMAGING AGENTS, THROUGH 2017 ($MILLIONS) 97TABLE 33 U.S. MARKET FOR SUPERPARAMAGNETIC MRI CONTRAST AGENTS, THROUGH2017 ($ MILLIONS) 99TABLE 34 U.S. MARKET FOR HYPERPOLARIZED MRI CONTRAST AGENTS, THROUGH 2017 ($MILLIONS) 100TABLE 35 U.S. MARKET FOR APTAMER-BASED IMAGING AGENTS, THROUGH 2017 ($MILLIONS) 100TABLE 36 U.S. MARKET FOR NANOPARTICLE-BASED OPTICAL IMAGING AGENTS, THROUGH2017 ($ MILLIONS) 101TABLE 37 U.S. MARKET FOR NANOSHELL-BASED OPTICAL IMAGING AGENTS, THROUGH2017 ($ MILLIONS) 101TABLE 38 U.S. MARKET FOR DIAGNOSTIC APPLICATIONS OF THZ RADIATION, THROUGH2017 ($ MILLIONS) 106TABLE 39 U.S. MARKET FOR TERAHERTZ SKIN CANCER IMAGING EQUIPMENT, THROUGH2017 ($ MILLIONS) 107TABLE 40 U.S. MARKET FOR TERAHERTZ ENDOSCOPES, THROUGH 2017 ($ MILLIONS) 108TABLE 41 U.S. MARKET FOR TERAHERTZ BURN DIAGNOSTIC INSTRUMENTS THROUGH 2017($ MILLIONS) 108TABLE 42 U.S. MARKET FOR TERAHERTZ BIOCHIPS USED IN MEDICAL DIAGNOSTICSAPPLICATIONS, THROUGH 2017 ($ MILLIONS) 109TABLE 43 U.S. MARKET FOR EMERGING WIRELESS DIAGNOSTIC TECHNOLOGIES, THROUGH2017 ($ MILLIONS) 113TABLE 44 U.S. MARKET FOR NFC-ENABLED MOBILE DEVICE DIAGNOSTICS, THROUGH 2017($ MILLIONS) 115TABLE 45 U.S. MARKET FOR CAPSULE ENDOSCOPY SYSTEMS, THROUGH 2017 ($ MILLIONS) 115TABLE 46 U.S. MARKET FOR OTHER EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH2017 ($ MILLIONS) 118TABLE 47 U.S. MARKET FOR DIAGNOSTIC ELECTRONIC NOSES, THROUGH 2017 ($ MILLIONS) 119TABLE 48 U.S. MARKET FOR DENDRIMER-BASED DIAGNOSTIC REAGENTS, THROUGH 2017 ($MILLIONS) 120 LIST OF FIGURES SUMMARY FIGURE U.S. MARKET FOR EMERGING DIAGNOSTIC TECHNOLOGIES, THROUGH 2017 ($ MILLIONS) 6 FIGURE 1 TREND IN THE NUMBER OF U.S. HOSPITALS, 1995-2010 (UNITS) 15 FIGURE 2 TREND IN THE NUMBER OF ACTIVE U.S. PHYSICIANS, 2002-2009 (THOUSANDS) 16 FIGURE 3 TRENDS IN U.S. EXPENDITURES ON HOME HEALTHCARE, 2000-2010 ($ BILLIONS) 18 FIGURE 4 U.S. MILITARY HEALTH EXPENDITURES, FY 2000-FY 2011 ($ BILLIONS) 18 FIGURE 5 TRENDS IN U.S. PER CAPITA HEALTHCARE COSTS, 1990-2010 ($ PER PERSON) 33 FIGURE 6 U.S. PATENTS RELATING TO EMERGING DIAGNOSTIC TECHNOLOGIES (NUMBER OF PATENTS /% OF TOTAL PATENTS/) 36 FIGURE 7 U.S. PATENTS RELATING TO EMERGING DIAGNOSTIC TECHNOLOGIES (% OF TOTAL PATENTS/NUMBER OF PATENTS) 38 FIGURE 8 TRENDS IN U.S. DIAGNOSTIC ULTRASOUND MARKET, 2011-2017 ($ MILLIONS) 43 FIGURE 9 TRENDS IN U.S. DIAGNOSTIC MRI MARKET, 2011-2017 ($ MILLIONS) 49 FIGURE 10 TRENDS IN U.S. MARKET FOR EMERGING NUCLEAR MEDICINE DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 55 FIGURE 11 TRENDS IN U.S. MARKET FOR EMERGING TOMOGRAPHIC DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 60 FIGURE 12 TRENDS IN U.S. MARKET FOR EMERGING PHOTONIC, OPTICAL AND SPECTROSCOPIC DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 67 FIGURE 13 TRENDS IN U.S. MARKET FOR EMERGING HYBRID DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 73 FIGURE 14 TRENDS IN U.S. MARKET FOR TELEDIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 78 FIGURE 15 TRENDS IN U.S. MARKET FOR DIAGNOSTIC LIS, 2011-2017 ($ MILLIONS) 84 FIGURE 16 TRENDS IN U.S. MARKET FOR DIAGNOSTIC DECISION SUPPORT SYSTEMS, 2011-2017 ($ MILLIONS) 93 FIGURE 17 TRENDS IN U.S. MARKET FOR EMERGING DIAGNOSTIC IMAGING AGENTS, 2011â 2017 ($ MILLIONS) 98 FIGURE 18 TRENDS IN U.S. MARKET FOR EMERGING TERAHERTZ DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 107 FIGURE 19 TRENDS IN U.S. MARKET FOR EMERGING WIRELESS DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 114 FIGURE 20 TRENDS IN U.S. MARKET OTHER EMERGING DIAGNOSTIC TECHNOLOGIES, 2011-2017 ($ MILLIONS) 118 To order this report:Medical_Imaging Industry: Emerging Diagnostic Technologies in the Changing U.S. Market Nicolas Bombourg Reportlinker Email: nicolasbombourg@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626 SOURCE Reportlinker

[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy